ArticleOPEN ACCESS

Ticagrelor breaks up the tumor-platelet party

Blood
DOI: 10.1182/blood-2017-07-795898
12Citations
Citations of this article
24Readers
Mendeley users who have this article in their library.

This article is free to access.

Abstract

In this issue of Blood, Cho et al demonstrate that blocking adenosine 5′-diphosphate (ADP) signaling to the P2Y12 receptor on platelets reduces the growth of ovarian cancer cells, implicating the P2Y12 inhibitor ticagrelor as a potential therapeutic option for primary and secondary prevention of ovarian cancer.1

Cite

CITATION STYLE

APA

Mitrugno, A., & McCarty, O. J. T. (2017, September 7). Ticagrelor breaks up the tumor-platelet party. Blood. American Society of Hematology. https://doi.org/10.1182/blood-2017-07-795898

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free